← Leaderboards
Moise Desvarieux
Columbia University Health Sciences
$16,545,538
Attributed
$20,136,979
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$20,136,979 · 4
By mechanism
R01$14,378,683 · 1
R56$5,387,161 · 1
R21$216,231 · 1
M01$154,904 · 1
Top collaborators
- George M. Hripcsak1 shared
- Richard Mayeux1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Ryan T. Demmer$5,389,015
- Regina M Santella$21,752,808
- Randolph S Marshall$10,866,382
- Steven P Engebretson$11,664,123
- Denise B Kandel$14,719,404
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisStrokeFutureIncidenceHypertensionEvaluationInfectionClinical ResearchGenderRisk FactorsCytokineChronicResearch PersonnelPersonsInterviewCohortVascular DiseasesDiabetes MellitusFollow-UpCholesterolHuman SubjectCessation Of LifeEventCarotid Atherosclerotic Disease
Grant awards (20)
Multi-morbidity 3-City Alzheimer's Disease EHR Study (M3AD Study)$5,387,161
R56 · FY2024 · AG · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$665,052
R01 · FY2016 · DE · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$742,506
R01 · FY2015 · DE · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$755,626
R01 · FY2014 · DE · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$720,791
R01 · FY2013 · DE · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$767,539
R01 · FY2012 · DE · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$1,327,242
R01 · FY2010 · DE · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$1,348,530
R01 · FY2009 · DE · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$1,333,221
R01 · FY2008 · DE · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$1,364,493
R01 · FY2007 · DE · contact PI
Oral Infections and Vascular Disease Epidemiology Study (INVEST)$1,396,986
R01 · FY2006 · DE · contact PI
ORAL INFECTIONS, CAROTID ATHEROSCLEROSIS &STROKE STUDY$55,482
M01 · FY2005 · RR
ORAL INFECTIONS, CAROTID ATHEROSCLEROSIS AND STROKE$799,503
R01 · FY2004 · DE
Oral Infections, Carotid Atherosclerosis &Stroke Study$99,422
M01 · FY2004 · RR
ORAL INFECTIONS, CAROTID ATHEROSCLEROSIS AND STROKE$791,548
R01 · FY2003 · DE
ORAL INFECTIONS, CAROTID ATHEROSCLEROSIS AND STROKE$766,241
R01 · FY2002 · DE
ORAL INFECTIONS, CAROTID ATHEROSCLEROSIS AND STROKE$799,051
R01 · FY2001 · DE
ORAL INFECTIONS AND VASCULAR RISK IN SEVEN COUNTRIES$109,465
R21 · FY2001 · DE
ORAL INFECTIONS, CAROTID ATHEROSCLEROSIS AND STROKE$800,354
R01 · FY2000 · DE
ORAL INFECTIONS AND VASCULAR RISK IN SEVEN COUNTRIES$106,766
R21 · FY2000 · DE